文献速递消化、代谢与肾脏急症心脑血管急症重症综合管理与镇静镇痛

八国新冠疫苗特别关注不良事件背景发生率的多国网络队列研究

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
PubMed 文献 · BMJ · 2021-06-14
一句话结论八国13个数据库显示15种新冠疫苗特别关注不良事件的背景发生率随年龄、性别和数据库差异巨大,安全监测前需分层或标准化。

该多国网络队列研究基于澳大利亚、法国、德国、日本、荷兰、西班牙、英国和美国13个数据库的电子健康记录和理赔数据,纳入126 661 070人,量化15种预设特别关注不良事件的背景发生率。结果显示事件率在数据库间差异很大,深静脉血栓在65-74岁女性中从英国CPRD GOLD的387/10万人年(95%CI 370-404)到美国IBM MarketScan Multi-State Medicaid的1443/10万人年(95%CI 1416-1470);部分事件随年龄增加,如美国Optum数据中男性心肌梗死从18-34岁的28/10万人年(95%CI 27-29)升至85岁以上的1400/10万人年(95%CI 1374-1427),而过敏反应等事件在年轻人中更常见。作者结论指出使用背景率进行安全监测前需按年龄和性别分层或标准化,数据库间存在显著人群水平异质性。

要点

  • 15种预设特别关注不良事件的背景发生率在8国13个数据库间差异很大,使用前需按年龄、性别和数据库分层或标准化。
  • 65-74岁女性深静脉血栓率:英国CPRD GOLD数据387/10万人年(95%CI 370-404)vs 美国IBM MarketScan Multi-State Medicaid数据1443/10万人年(95%CI 1416-1470)。
  • 美国Optum电子健康记录数据中男性心肌梗死率从18-34岁28/10万人年(95%CI 27-29)升至85岁以上1400/10万人年(95%CI 1374-1427)。
  • 美国Optum电子健康记录数据中男孩和男性过敏反应率:6-17岁78/10万人年(95%CI 75-80)vs 85岁以上8/10万人年(95%CI 6-10)。
  • 研究纳入126 661 070人,观察至少365天(截至2017、2018或2019年1月1日),覆盖13个数据库。

适用人群与场景

  • 来自澳大利亚、法国、德国、日本、荷兰、西班牙、英国和美国13个数据库的126 661 070人,观察至少365天(截至2017、2018或2019年1月1日)。
  • 数据来源为电子健康记录和健康理赔数据,映射至通用数据模型。

研究设计与关键结果

  • 研究设计为多国网络队列研究,纳入126 661 070人,来自8国13个数据库,评估15种预设特别关注不良事件。
  • 深静脉血栓率在65-74岁女性中:英国CPRD GOLD数据387/10万人年(95%CI 370-404)vs 美国IBM MarketScan Multi-State Medicaid数据1443/10万人年(95%CI 1416-1470)。
  • 美国Optum电子健康记录数据中男性心肌梗死率:18-34岁28/10万人年(95%CI 27-29)vs 85岁以上1400/10万人年(95%CI 1374-1427),随年龄增加。
  • 美国Optum电子健康记录数据中男孩和男性过敏反应率:6-17岁78/10万人年(95%CI 75-80)vs 85岁以上8/10万人年(95%CI 6-10),年轻人群更高。
  • 背景率在数据库间差异很大,部分事件随年龄增加,其他事件在年轻人中更常见;荟萃分析估计按年龄和性别分类。

证据类型、等级与局限

  • 证据类型:多国网络队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 使用背景率进行新冠疫苗安全监测前,需按年龄、性别和数据库分层或标准化,因事件率在数据库间存在显著人群水平异质性。

指南或共识出处

  • 研究数据来自澳大利亚、法国、德国、日本、荷兰、西班牙、英国和美国的13个数据库,映射至通用数据模型。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To quantify the background incidence rates of 15 prespecified adverse events of special interest (AESIs) associated with covid-19 vaccines.

DESIGN: Multinational network cohort study.

SETTING: Electronic health records and health claims data from eight countries: Australia, France, Germany, Japan, the Netherlands, Spain, the United Kingdom, and the United States, mapped to a common data model.

PARTICIPANTS: 126 661 070 people observed for at least 365 days before 1 January 2017, 2018, or 2019 from 13 databases.

MAIN OUTCOME MEASURES: Events of interests were 15 prespecified AESIs (non-haemorrhagic and haemorrhagic stroke, acute myocardial infarction, deep vein thrombosis, pulmonary embolism, anaphylaxis, Bell's palsy, myocarditis or pericarditis, narcolepsy, appendicitis, immune thrombocytopenia, disseminated intravascular coagulation, encephalomyelitis (including acute disseminated encephalomyelitis), Guillain-Barré syndrome, and transverse myelitis). Incidence rates of AESIs were stratified by age, sex, and database. Rates were pooled across databases using random effects meta-analyses and classified according to the frequency categories of the Council for International Organizations of Medical Sciences.

RESULTS: Background rates varied greatly between databases. Deep vein thrombosis ranged from 387 (95% confidence interval 370 to 404) per 100 000 person years in UK CPRD GOLD data to 1443 (1416 to 1470) per 100 000 person years in US IBM MarketScan Multi-State Medicaid data among women aged 65 to 74 years. Some AESIs increased with age. For example, myocardial infarction rates in men increased from 28 (27 to 29) per 100 000 person years among those aged 18-34 years to 1400 (1374 to 1427) per 100 000 person years in those older than 85 years in US Optum electronic health record data. Other AESIs were more common in young people. For example, rates of anaphylaxis among boys and men were 78 (75 to 80) per 100 000 person years in those aged 6-17 years and 8 (6 to 10) per 100 000 person years in those older than 85 years in Optum electronic health record data. Meta-analytic estimates of AESI rates were classified according to age and sex.

CONCLUSION: This study found large variations in the observed rates of AESIs by age group and sex, showing the need for stratification or standardisation before using background rates for safety surveillance. Considerable population level heterogeneity in AESI rates was found between databases.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Li X, Ostropolets A, Makadia R, et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021. PMID: 35727911. doi:10.1136/bmj.n1435

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。